A better understanding of the complex interactions between the immune system and tumour
cells from different origins has opened the possibility to design novel procedures of …

Adoptive cell therapy is a rapidly advancing approach to cancer immunotherapy that seeks
to facilitate antitumor responses by introducing potent effector cells into the tumor …

An emerging cellular immunotherapy for cancer is based on the cytolytic activity of natural
killer (NK) cells against a wide range of tumors. Although in vitro activation, or “priming,” of …

Natural killer (NK) cell-based immunotherapies treat hematopoietic malignancies, but are
less effective against solid tumors. Here, we review recent data on NK cell recognition of …

Natural killer (NK) cells are innate immune cells that recognize malignant cells through a
wide array of germline-encoded receptors. Triggering of activating receptors results in …

Natural killer (NK) cells are innate immune cells that are critical to the body's antitumor and
antimetastatic defense. As such, novel therapies are being developed to utilize NK cells as …

Natural killer (NK) cells comprise one subset of the innate lymphoid cell (ILC) family. Despite
reported antitumor functions of NK cells, their tangible contribution to tumor control in …

Cells of the innate immunity play an important role in tumor immunotherapy. Thus, NK cells
can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity …

Natural Killer (NK) cells are classically considered innate immune effector cells involved in
the first line of defense against infected and malignant cells. More recently, NK cells have …

Gastrointestinal cancer is one of the leading health problems worldwide, with a high
morbidity and mortality. To date, harnessing both the innate and adaptive immune system …